- Sprache
-
Englisch
- Umfang
-
X, 401 S. 8"
- Standort
-
München, Bayerische Staatsbibliothek -- Path. 199 b
Thema
Liver Diseases; Liver / Diseases
Beteiligte Personen und Organisationen
Erschienen
London : Churchill, 1845
- URN
-
urn:nbn:de:bvb:12-bsb10471063-5
- Letzte Aktualisierung
-
16.04.2024, 14:02 MESZ
Entstanden
- London : Churchill, 1845
Ähnliche Objekte (12)
Identification of Metabolic Prognostic Markers in Liver Diseases After Carbon Tetrachloride Intoxication
TGF-β2 abundance in mice and men: A successful anti-TGF-β2 strategy in biliary-derived liver disease
Observations sur la nature et le traitement des maladies du foie
Bias Invariant RNA-Seq Data Annotation and Liver Diseases Microbiome Analysis
Hepatocyte-specific role of the deubiquitinating enzyme OTUB1 during inflammatory liver diseases
Benefits of albumin administration for patients with chronic liver diseases
Potential new biomarkers for liver diseases : SEPT6 and serum zinc levels
Case III.
Definitions.
Introduction.
Plate III.
Case II.
Identification of Metabolic Prognostic Markers in Liver Diseases After Carbon Tetrachloride Intoxication
TGF-β2 abundance in mice and men: A successful anti-TGF-β2 strategy in biliary-derived liver disease
Observations sur la nature et le traitement des maladies du foie
Bias Invariant RNA-Seq Data Annotation and Liver Diseases Microbiome Analysis
Hepatocyte-specific role of the deubiquitinating enzyme OTUB1 during inflammatory liver diseases
Benefits of albumin administration for patients with chronic liver diseases
Potential new biomarkers for liver diseases : SEPT6 and serum zinc levels
Case III.
Definitions.
Introduction.
Plate III.
Case II.
Identification of Metabolic Prognostic Markers in Liver Diseases After Carbon Tetrachloride Intoxication
TGF-β2 abundance in mice and men: A successful anti-TGF-β2 strategy in biliary-derived liver disease
Observations sur la nature et le traitement des maladies du foie
Bias Invariant RNA-Seq Data Annotation and Liver Diseases Microbiome Analysis
Hepatocyte-specific role of the deubiquitinating enzyme OTUB1 during inflammatory liver diseases
Benefits of albumin administration for patients with chronic liver diseases
Potential new biomarkers for liver diseases : SEPT6 and serum zinc levels
Case III.
Definitions.
Introduction.
Plate III.